The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Overweight and obesity are contributing to rising death rates from bowel cancer among people aged…
Subcutaneous injection of the immunotherapy nivolumab is non-inferior to intravenous delivery and dramatically reduces treatment…
Copper is an essential trace element required to produce energy in the body and allows…
Scientists have developed two agents, made of therapeutic nanoparticles and antibodies, that could be given…
The dual immunotherapy combination of nivolumab and ipilimumab reduced the risk of disease progression or…
The role of ctDNA, or liquid biopsy, as a predictive tool to guide and monitor…
Results from a new phase III study found that combining PD-L1 and TIGIT inhibitors plus…
The addition of durvalumab and bevacizumab to TACE significantly improved progression-free survival in patients with…
Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend…
The current standard of care for identifying targetable mutations in cancer treatment is to conduct…